Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis
Dan G. Duda(Harvard University), S Matsuno, Fuyuhiko Motoi(Tohoku University), Yoshihiko Nakamura(National Institute of Technology, Tomakomai College), Akira Horii(Tohoku University), Toshimasa Yatsuoka(Saitama Cancer Center), Toshihiko Yokoyama(Japanese Red Cross Nagoya Daiichi Hospital), Lucian Lozonschi(Tampa General Hospital), Kotaro Tani(Tokyo University of Science), Makoto Sunamura(Cancer Research UK), S Asano(Hiroshima University)
Cited by 48
Related Papers
Identification of FAP Locus Genes from Chromosome 5q21
|Science|1991|2.4k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
|Nature Clinical Practice Oncology|2006|1k
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
|Angiogenesis|2017|690
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
|Japanese Journal of Clinical Oncology|2018|534